The University of Illinois Cancer Center Pilot Fund opportunity is designed to provide two “seed” money awards for the initiation of promising new collaborative projects. The seed funding will support applications that demonstrate promise for MPI/R01 funding and align with the CPC specific aims (see below). The Cancer Center is funding these awards to advance promising new research among CPC members and the UIC community. The goals of the CPC Cancer Center Pilot Program are to: (1) foster outstanding cancer prevention, control and survivorship research at UIC by supporting the development of preliminary data that can be used to launch new NIH or other externally-funded peer-reviewed cancer research proposals, and (2) enhance interdisciplinary collaboration between investigators in CPC and across the Cancer Center as well as the institution.
CPC Program specific aims:
Aim 1. To reduce cancer risk through the promotion of early detection and screening behaviors and to advance the development of innovative interventions. Emphasis is on tobacco use, poor diet quality, physical inactivity, obesity, screening adherence, access to screening and environmental/neighborhood risks, since these are major determinants of cancer risk.
Aim 2. To improve outcomes relevant to cancer management, treatment adherence and survivorship. This aim focuses on identifying effective interventions and understanding how multiple factors (e.g., biological, psychosocial, cultural, access to quality care, social networks, social support, and policy) impact cancer management, quality of life and ultimately, health outcomes.
- Only cancer-focused studies with high scientific merit will be considered.
- At least one MPI and one additional team member must be CPC members.
- At least one of the investigators must have a strong record of peer-reviewed funding.
- Preference for applications that include 1 junior CPC member with 1 senior faculty CPC member.
- Applications that include inter-programmatic collaborators (i.e., Cancer Biology and Translational Oncology) are encouraged.
- Only projects that can begin by October 15, 2019 will be considered with approved IRB.
- Projects are for one (1) year
- Use of RRC Shared Resources is encouraged
- Projects utilizing the UIC Federally Qualified Health Centers (FQHCs) are encouraged
Areas of Research Interest
- Research addressing University of Illinois Cancer Center catchment area relevant cancers (i.e., breast, lung, prostate, colorectal)
- Research integrating existing datasets to understand cancer risk disparities and cancer treatment and outcome disparities
- Research examining biological, environmental/occupational exposures and cultural/social factors that may explain differential risk patterns for cancer
- Research focused on interventions and policies focused on improving health outcomes during cancer treatment and survivorship
I. MPI/R01 Application Development Award
The purpose of this RFA is to stimulate the development of high-quality, multi-principal investigator (MPI) projects that will move forward to nationally-funded grant awards. Areas of thematic investigation are open, provided they maintain a clear cancer focus. Health equity research is encouraged, with an emphasis on the cancers more prevalent in our catchment area (i.e. breast, colorectal, lung, prostate), The CPC program leadership anticipates distributing two awards of $75,000 (max) for one year. The one-year grant is available to all CPC members post-doctoral fellows are not eligible) . A Letter of Intent (LOI) is required, due July 16, 2019. LOIs will be reviewed and eligible applicants (4 LOIs) notified by July 31, 2019. Complete applications will be due September 3, 2019 (those invited will be provided separate instructions related to the application).
Funding: $75,000 (max) for one year – two awards
Deadline: LOI due August 9th, 2019 (5:00 PM CST); eligible applicants notified by July 31, 2019. Complete applications due September 3, 2019 (5:00 PM CST). Complete applications will be peer reviewed by external reviewers. Awardees notified by October 4, 2019. Funds will be released as early as October 15, 2019 with approved IRB. Applicants are encouraged to submit IRB if invited to submit a full proposal.
Letter of Intent Format:
- Name and College/Departmental Affiliation of MPIs
- Project Title
- Lay language summary (200 words)
- How will the proposed project extend collaborations or develop new areas of cancer research for the investigator? Clearly state how the proposed work is distinct from the MPIs ongoing collaborations.
- Plan for R01 funding
- Co-investigators including name, affiliation, cancer center membership (Y/N)/University of Illinois Cancer Center program, and area of expertise
Applicants are strongly encouraged to seek advice about applications from Marian Fitzgibbon, PhD (AD for CPC, email@example.com), Ardith Doorenbos (Program Co-leader for CPC, (firstname.lastname@example.org), and Lisa Tussing-Humphreys, PhD (Program Co-leader for CPC, email@example.com). Please direct administrative questions to Mirjana Antonic (firstname.lastname@example.org) as soon as possible.